Publication | Closed Access
A Phase II Study of Capecitabine plus Oxaliplatin as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer
32
Citations
35
References
2012
Year
The XELOX regimen with capecitabine at a lower dose of 850 mg/m(2) is active, fairly tolerable and conveniently delivered as first-line chemotherapy for elderly AGC patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1